DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank-check company formed to pursue a merger or acquisition in the life sciences and healthcare technology sector. The company completed its IPO in 2021 and, as reflected in its 10-Q filed with the SEC on August 15, 2022 (accession no. 0001193125-22-221227), remained in the search phase for a qualifying business combination target at that time. DALS was sponsored by DA32 Management LLC, an entity organized specifically to support the vehicle's acquisition strategy within the life science technology space. Sign up for full data, filings, and deal-status alerts on SpacDesk.